Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1076

1.

Japanese Versus Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: Subanalysis of TIA registry.org.

Uchiyama S, Hoshino T, Sissani L, Linsay MT, Kamiyama K, Nakase T, Kitagawa K, Minematsu K, Todo K, Okada Y, Nakagawara J, Nagata K, Yamagami H, Yamaguchi T, Amarenco P; TIAregistry.org Investigators.

J Stroke Cerebrovasc Dis. 2019 Jun 6. pii: S1052-3057(19)30225-3. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.005. [Epub ahead of print]

2.

ATP hydrolysis by KaiC promotes its KaiA binding in the cyanobacterial circadian clock system.

Yunoki Y, Ishii K, Yagi-Utsumi M, Murakami R, Uchiyama S, Yagi H, Kato K.

Life Sci Alliance. 2019 Jun 3;2(3). pii: e201900368. doi: 10.26508/lsa.201900368. Print 2019 Jun.

3.

Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS.

Uchiyama S, Toyoda K, Kitagawa K, Okada Y, Ameriso S, Mundl H, Berkowitz S, Yamada T, Liu YY, Hart RG; NAVIGATE ESUS Investigators.

Int J Stroke. 2019 May 27:1747493019852177. doi: 10.1177/1747493019852177. [Epub ahead of print]

PMID:
31132967
4.

Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.

Sakuma I, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H.

Heart Vessels. 2019 May 24. doi: 10.1007/s00380-019-01425-x. [Epub ahead of print]

PMID:
31127325
5.

Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.

Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K; CSPS.com Trial Investigators.

Lancet Neurol. 2019 Jun;18(6):539-548. doi: 10.1016/S1474-4422(19)30148-6.

PMID:
31122494
6.

A rare case of simultaneous rectal and gastric carcinomas accompanied with inferior mesenteric arterioportal fistula: case report.

Kai K, Sano K, Higuchi K, Uchiyama S, Sueta H, Nanashima A.

Surg Case Rep. 2019 May 17;5(1):82. doi: 10.1186/s40792-019-0630-9.

7.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators.

N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.

PMID:
31091372
8.

Mutational and Combinatorial Control of Self-Assembling and Disassembling of Human Proteasome α Subunits.

Sekiguchi T, Satoh T, Kurimoto E, Song C, Kozai T, Watanabe H, Ishii K, Yagi H, Yanaka S, Uchiyama S, Uchihashi T, Murata K, Kato K.

Int J Mol Sci. 2019 May 9;20(9). pii: E2308. doi: 10.3390/ijms20092308.

9.

[Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging].

Nakano K, Ito Y, Takagi F, Uchiyama S, Yoda A, Sakamoto N, Takaba M, Adachi M, Takemura T, Nagata Y, Ono T.

Rinsho Ketsueki. 2019;60(4):302-307. doi: 10.11406/rinketsu.60.302. Japanese.

PMID:
31068560
10.

Biomechanical analysis of volleyball overhead pass.

Ozawa Y, Uchiyama S, Ogawara K, Kanosue K, Yamada H.

Sports Biomech. 2019 May 8:1-14. doi: 10.1080/14763141.2019.1609072. [Epub ahead of print]

PMID:
31066350
11.

A new technique to determine the tension in extensor pollicis longus reconstruction.

Kamoi F, Kondo M, Hayashi M, Uchiyama S, Kato H.

J Hand Surg Eur Vol. 2019 May 2:1753193419845281. doi: 10.1177/1753193419845281. [Epub ahead of print]

PMID:
31046534
12.

Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin.

Wada S, Koga M, Minematsu K, Toyoda K, Suzuki R, Kagimura T, Nagai Y, Aoki S, Nezu T, Hosomi N, Origasa H, Ohtsuki T, Maruyama H, Yasaka M, Kitagawa K, Uchiyama S, Matsumoto M.

Stroke. 2019 Jun;50(6):1586-1589. doi: 10.1161/STROKEAHA.119.024968. Epub 2019 Apr 30.

PMID:
31035902
13.

Comparison of Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Relation to Outcomes in Patients Diagnosed with Acute Coronary Syndrome During Winter -vs- Other Seasons.

Shibuya J, Kobayashi N, Asai K, Tsurumi M, Shibata Y, Uchiyama S, Okazaki H, Goda H, Tani K, Shirakabe A, Takano M, Shimizu W.

Am J Cardiol. 2019 Jul 1;124(1):31-38. doi: 10.1016/j.amjcard.2019.03.045. Epub 2019 Apr 8.

PMID:
31027656
14.

Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks.

Ando K, Shimada K, Yamazaki T, Uchiyama S, Uemura Y, Ishizuka N, Teramoto T, Oikawa S, Sugawara M, Murata M, Yokoyama K, Ikeda Y; Japanese Primary Prevention Project (JPPP) Study Group.

J Hypertens. 2019 Jun;37(6):1301-1307. doi: 10.1097/HJH.0000000000002034.

PMID:
31022110
15.

Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke.

Tanaka T, Yamagami H, Ihara M, Miyata T, Miyata S, Hamasaki T, Amano S, Fukuma K, Yamamoto H, Nakagawara J, Furui E, Uchiyama S, Hyun B, Yamamoto Y, Manabe Y, Ito Y, Fukunaga R, Abumiya T, Yasaka M, Kitagawa K, Toyoda K, Nagatsuka K.

Circ J. 2019 May 24;83(6):1385-1393. doi: 10.1253/circj.CJ-18-1386. Epub 2019 Apr 19.

16.

Ulnar neuropathy at the elbow in 413 Japanese patients: An assessment of pathological elbow lesions and neurological severity.

Sato N, Okita G, Uchiyama S, Matsui Y, Wakabayashi Y, Ishii S, Kuniyoshi K, Hirachi K, Haro H, Kato H.

J Orthop Sci. 2019 Apr 17. pii: S0949-2658(19)30111-3. doi: 10.1016/j.jos.2019.03.018. [Epub ahead of print]

PMID:
31005383
17.

Psychometric validation of anti-clot treatment scale and treatment satisfaction questionnaire for medication version II in Japanese patients with atrial fibrillation.

Watanabe-Fujinuma E, Banderas BF, Koretsune Y, Kumagai K, Uchiyama S, Yamashita T, Yasaka M, Akiyama S, Briere JB, Dickie G, Cano SJ.

J Med Econ. 2019 Apr 17:1-8. doi: 10.1080/13696998.2019.1609003. [Epub ahead of print]

PMID:
30995146
18.

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE, Haeusler KG, Mikulik R, Kasner SE, Toni D, Arauz A, Ntaios G, Hankey GJ, Perera K, Pagola J, Shuaib A, Lutsep H, Yang X, Uchiyama S, Endres M, Coutts SB, Karlinski M, Czlonkowska A, Molina CA, Santo G, Berkowitz SD, Hart RG, Connolly SJ.

JAMA Neurol. 2019 Apr 8. doi: 10.1001/jamaneurol.2019.0617. [Epub ahead of print]

PMID:
30958508
19.

Precise Proton Mapping near Ionic Micellar Membranes with Fluorescent Photoinduced-Electron-Transfer Sensors.

Uchiyama S, Yano K, Fukatsu E, de Silva AP.

Chemistry. 2019 Apr 4. doi: 10.1002/chem.201806270. [Epub ahead of print]

PMID:
30947361
20.

Temperature-controlled repeatable scrambling and induced-sorting of building blocks between cubic assemblies.

Zhan YY, Kojima T, Ishii K, Takahashi S, Haketa Y, Maeda H, Uchiyama S, Hiraoka S.

Nat Commun. 2019 Mar 29;10(1):1440. doi: 10.1038/s41467-019-09495-1.

21.

Small vessel occlusion is a high-risk etiology for early recurrent stroke after transient ischemic attack.

Ohara T, Uehara T, Sato S, Hayakawa M, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; PROMISE-TIA Study Investigators.

Int J Stroke. 2019 Mar 27:1747493019840931. doi: 10.1177/1747493019840931. [Epub ahead of print]

PMID:
30917776
22.

Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing.

Uchiyama S, Sun J, Fukahori K, Ando N, Wu M, Schwarz F, Siddiqui SS, Varki A, Marth JD, Nizet V.

Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7465-7470. doi: 10.1073/pnas.1815572116. Epub 2019 Mar 25.

PMID:
30910970
23.

Temperature imaging using a cationic linear fluorescent polymeric thermometer and fluorescence lifetime imaging microscopy.

Inada N, Fukuda N, Hayashi T, Uchiyama S.

Nat Protoc. 2019 Apr;14(4):1293-1321. doi: 10.1038/s41596-019-0145-7. Epub 2019 Mar 22.

PMID:
30903107
24.

Ionic liquids and protein folding-old tricks for new solvents.

Wakayama R, Uchiyama S, Hall D.

Biophys Rev. 2019 Apr;11(2):209-225. doi: 10.1007/s12551-019-00509-2. Epub 2019 Mar 19. Review.

25.

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-Dabigatran Surveillance.

Inoue H, Uchiyama S, Atarashi H, Okumura K, Koretsune Y, Yasaka M, Yamashita T, Taniguchi A, Fukaya T; J-Dabigatran Surveillance Investigators.

J Cardiol. 2019 Aug;74(2):156-163. doi: 10.1016/j.jjcc.2019.02.008. Epub 2019 Mar 12.

PMID:
30871851
26.

Identification of IgG1 Aggregation Initiation Region by Hydrogen Deuterium Mass Spectrometry.

Noda M, Ishii K, Yamauchi M, Oyama H, Tadokoro T, Maenaka K, Torisu T, Uchiyama S.

J Pharm Sci. 2019 Mar 6. pii: S0022-3549(19)30141-8. doi: 10.1016/j.xphs.2019.02.023. [Epub ahead of print]

PMID:
30851343
27.

Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers.

Shirakabe A, Hata N, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, Uchiyama S, Sawatani T, Asai K, Shimizu W.

ESC Heart Fail. 2019 Apr;6(2):416-427. doi: 10.1002/ehf2.12414. Epub 2019 Feb 23.

28.

An Assessment of the Ability of Submicron- and Micron-Size Silicone Oil Droplets in Dropped Prefillable Syringes to Invoke Early- and Late-Stage Immune Responses.

Krayukhina E, Yokoyama M, Hayashihara KK, Maruno T, Noda M, Watanabe H, Uchihashi T, Uchiyama S.

J Pharm Sci. 2019 Feb 18. pii: S0022-3549(19)30086-3. doi: 10.1016/j.xphs.2019.02.002. [Epub ahead of print]

29.

SDS-induced oligomerization of Lys49-phospholipase A2 from snake venom.

Matsui T, Kamata S, Ishii K, Maruno T, Ghanem N, Uchiyama S, Kato K, Suzuki A, Oda-Ueda N, Ogawa T, Tanaka Y.

Sci Rep. 2019 Feb 20;9(1):2330. doi: 10.1038/s41598-019-38861-8.

30.

Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).

Ogawa A, Toyoda K, Kitagawa K, Kitazono T, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y; PRASTRO-I Study Group.

Lancet Neurol. 2019 Mar;18(3):238-247. doi: 10.1016/S1474-4422(18)30449-6. Epub 2019 Feb 12.

PMID:
30784555
31.

Impact of Accumulated Serum Uric Acid on Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Cardiac Outcomes in Patients with Acute Coronary Syndrome.

Kobayashi N, Asai K, Tsurumi M, Shibata Y, Okazaki H, Shirakabe A, Goda H, Uchiyama S, Tani K, Takano M, Shimizu W.

Cardiology. 2018;141(4):190-198. doi: 10.1159/000496053. Epub 2019 Feb 13.

PMID:
30759435
32.

Rivaroxaban administration after acute ischemic stroke: The RELAXED study.

Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T, Yamagami H, Nagao T, Yoshimura S, Uchiyama S; RELAXED study group.

PLoS One. 2019 Feb 13;14(2):e0212354. doi: 10.1371/journal.pone.0212354. eCollection 2019.

33.

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study.

Koretsune Y, Kusakawa K, Harada KH, Koizumi A, Uchiyama S, Atarashi H, Okumura K, Yasaka M, Yamashita T, Taniguchi A, Fukaya T, Inoue H; for J-dabigatran surveillance and JAPAF study investigators.

Cardiol Ther. 2019 Jun;8(1):43-54. doi: 10.1007/s40119-019-0129-2. Epub 2019 Feb 11.

34.

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance.

Inoue H, Uchiyama S, Atarashi H, Okumura K, Koretsune Y, Yasaka M, Yamashita T, Taniguchi A, Fukaya T; J-Dabigation Surveillance Investigators.

J Cardiol. 2019 Jun;73(6):507-514. doi: 10.1016/j.jjcc.2018.12.013. Epub 2019 Feb 5.

PMID:
30737182
35.

Crystal structure of the dog allergen Can f 6 and structure-based implications of its cross-reactivity with the cat allergen Fel d 4.

Yamamoto K, Ishibashi O, Sugiura K, Ubatani M, Sakaguchi M, Nakatsuji M, Shimamoto S, Noda M, Uchiyama S, Fukutomi Y, Nishimura S, Inui T.

Sci Rep. 2019 Feb 6;9(1):1503. doi: 10.1038/s41598-018-38134-w.

36.

[JIRA's Activity toward the Global Convergence of Medical Device Regulation].

Uchiyama S.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(1):125-127. doi: 10.6009/jjrt.2019_JSRT_75.1.125. Japanese. No abstract available.

37.

The prognostic impact of the uric acid level in patients who require cardiovascular intensive care - is serum uric acid a surrogate biomarker for critical patients in the non-surgical intensive care unit?

Shibata Y, Shirakabe A, Okazaki H, Matsushita M, Sawatani T, Uchiyama S, Tani K, Kobayashi N, Otsuka T, Hata N, Asai K, Shimizu W.

Eur Heart J Acute Cardiovasc Care. 2019 Jan 17:2048872618822473. doi: 10.1177/2048872618822473. [Epub ahead of print]

PMID:
30652942
38.

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care.

Okazaki H, Shirakabe A, Matsushita M, Shibata Y, Sawatani T, Uchiyama S, Tani K, Murase T, Nakamura T, Takayasu T, Asano M, Kobayashi N, Hata N, Asai K, Shimizu W.

ESC Heart Fail. 2019 Apr;6(2):336-343. doi: 10.1002/ehf2.12390. Epub 2019 Jan 8.

39.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70).

Sugawara M, Goto Y, Yamazaki T, Teramoto T, Oikawa S, Shimada K, Uchiyama S, Ando K, Ishizuka N, Murata M, Yokoyama K, Uemura Y, Ikeda Y; Japanese Primary Prevention Project (JPPP) Study Group.

Am J Cardiovasc Drugs. 2019 Jun;19(3):299-311. doi: 10.1007/s40256-018-0313-0.

PMID:
30565155
40.

Interlaboratory comparison about feasibility of insoluble particulate matter test for injections with reduced test volume in light obscuration method.

Harazono A, Shibata H, Kiyoshi M, Muto T, Fukuda J, Torisu T, Saitoh S, Nishimura H, Uchiyama S, Ishii-Watabe A.

Biologicals. 2019 Jan;57:46-49. doi: 10.1016/j.biologicals.2018.12.003. Epub 2018 Dec 13.

41.

[Toward the Proper Biophysical Characterization of Aggregates in Biopharmaceuticals].

Uchiyama S.

Yakugaku Zasshi. 2018;138(12):1503-1507. doi: 10.1248/yakushi.18-00020-4. Review. Japanese.

42.

[Current Trends in Analytical Technologies Which Promote the Development of Biopharmaceuticals].

Ishii-Watabe A, Uchiyama S.

Yakugaku Zasshi. 2018;138(12):1473-1474. doi: 10.1248/yakushi.18-00020-F. Japanese. No abstract available.

43.

Long waiting time before tooth extraction may increase delayed wound healing in elderly Japanese.

Kamimura M, Taguchi A, Komatsu M, Koiwai H, Ashizawa R, Ichinose A, Takahara K, Uchiyama S, Kato H.

Osteoporos Int. 2019 Mar;30(3):621-628. doi: 10.1007/s00198-018-4775-3. Epub 2018 Nov 20.

PMID:
30460382
44.

Enhanced topical delivery of non-complexed molecular iodine for Methicillin-resistant Staphylococcus aureus decolonization.

Uchiyama S, Dahesh S, Nizet V, Kessler J.

Int J Pharm. 2019 Jan 10;554:81-86. doi: 10.1016/j.ijpharm.2018.11.004. Epub 2018 Nov 2.

PMID:
30395958
45.

Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair.

Fukushima T, Uchiyama S, Tanaka H, Kataoka H.

Int J Mol Sci. 2018 Nov 1;19(11). pii: E3435. doi: 10.3390/ijms19113435. Review.

46.

Assembly of protein complexes restricts diffusion of Wnt3a proteins.

Takada R, Mii Y, Krayukhina E, Maruyama Y, Mio K, Sasaki Y, Shinkawa T, Pack CG, Sako Y, Sato C, Uchiyama S, Takada S.

Commun Biol. 2018 Oct 10;1:165. doi: 10.1038/s42003-018-0172-x. eCollection 2018.

47.

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA.

Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M; J-STARS collaborators.

J Atheroscler Thromb. 2019 May 1;26(5):432-441. doi: 10.5551/jat.45989. Epub 2018 Oct 15.

48.

Reliability and Concurrent Validity of the Ring Gauge Method and the Metacarpal Head Tape Measure Method of Measuring Hand Size.

Yamazaki H, Sakurai T, Uchiyama S, Kato H.

J Hand Surg Asian Pac Vol. 2018 Sep;23(3):382-387. doi: 10.1142/S2424835518500418.

PMID:
30282555
49.

Quantitative Laser Diffraction for Quantification of Protein Aggregates: Comparison With Resonant Mass Measurement, Nanoparticle Tracking Analysis, Flow Imaging, and Light Obscuration.

Yoneda S, Niederleitner B, Wiggenhorn M, Koga H, Totoki S, Krayukhina E, Friess W, Uchiyama S.

J Pharm Sci. 2019 Jan;108(1):755-762. doi: 10.1016/j.xphs.2018.09.004. Epub 2018 Sep 17.

50.

Bone Peg Grafting for Capitellar Osteochondritis Dissecans in Adolescent Baseball Players.

Oshiba H, Itsubo T, Komatsu M, Uchiyama S, Kato H.

JBJS Essent Surg Tech. 2018 Mar 14;8(1):e8. doi: 10.2106/JBJS.ST.17.00058. eCollection 2018 Mar 28.

Supplemental Content

Loading ...
Support Center